BP000031-GD5: Recombinant Heparinase I from Flavobacterium heparinum
Source: E. coli-derived.
Specific activity >100 IU/mg. One international unit (IU) of recombinant Heparinase I is defined as the amount of enzyme that will liberate 1.0 umole unsaturated oligosaccharides from porcine mucosal heparin per minute at 30°C and pH 7.0.
Purity >95% by SDS-PAGE.BP000032-GD6: Recombinant Heparinase II from Flavobacterium heparinum
Source: E. coli-derived.
Specific activity >6 IU/mg. One international unit (IU) of recombinant Heparinase II is defined as the amount of enzyme that will liberate 1.0 umole unsaturated oligosaccharides from heparin or heparan sulfate per minute at 30°C and pH 7.3.
Purity >95% by SDS-PAGE.BP000033-GD7: Recombinant Heparinase III from Flavobacterium heparinum
Source: E. coli-derived.
Specific activity >50 IU/mg. One international unit (IU) of recombinant Heparinase III is defined as the amount of enzyme that will liberate 1.0 umole unsaturated oligosaccharides from heparan sulfate per minute at 30°C and pH 7.3.
Purity >95% by SDS-PAGE.BP003061: Recombinant Human ACE2-His-Avi Protein (rhACE2-His)
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003055: Biotinylated Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S1-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003054: Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized recombinant SARS-CoV-2 Spike S1-His-Avi protein at 0.5 ug/ml (100 ul/well). Dose response curve for the biotinylated recombinant human ACE2-His fusion protein with the EC50 of 0.2 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003051: Biotinylated Recombinant SARS-CoV-2 Spike RBD-His-Avi (S1 RBD)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike RBD-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 100 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.C035P: Spartalizumab Biosimilar, PD-1 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade spartalizumab biosimilar specifically binds to the programmed cell death protein 1 (PD-1), antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by spartalizumab.BP003084: Recombinant Human M-CSF R / CSF1R / CD115 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003085: Biotinylated Recombinant Human Nectin-4 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.